New screening tests for TB

>
By  |  February 15, 2009 | 

In this cost effective analysis, researchers compared traditional skin testing for latent TB to newer interferon-gamma release assays (FDA approved recently). These assays work by incubating a blood sample with tuberculous antigen, and measuring the release of interferon (only tuberculous sensitized individuals will release interferon). They found these assays to be more cost-effective for screening, given they can be given to all individuals (even BCG-vaccinated), only require 1 visit, and do not require any interpretation. These tests will likely supplant skin testing in the near future (abstract).

Share This Post

Leave A Comment

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

About the Author: Danielle Scheurer

Danielle Scheurer, MD, MSCR, SFHM is a clinical hospitalist and the Chief Quality Officer at the Medical University of South Carolina in Charleston, South Carolina, where she also serves as Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She is also the President of SHM's Board of Directors and previously served as Physician Editor of The Hospitalist, SHM's monthly newsmagazine.

Categories

Related Posts

By Dhaval Desai, MD
August 17, 2021 |  5
During the first two to three weeks of the pandemic in 2020, I was involved in a lot of meetings about the current status and future plans for the impending surge of COVID-19 patients we were anticipating. It was during that time we witnessed COVID-19 ravaging cities like New York City. In one of the […]
By Swati Mehta, MD, FACP
April 9, 2021 |  1
The COVID-19 pandemic has changed health care as we know it. It has sowed fear and doubt among the public and created endless questions without answers. Our hospitalized patients may wonder why they can’t have their families beside them and worry about contracting the virus in the hospital. Strict visitation policies only add to their […]
By Saurin Gandhi DO, Kristin Mondy MD, Johanna Busch MD, W. Michael Brode MD
April 7, 2021 |  0
This article is part of a series in The Hospital Leader written by members of the Division of Hospital Medicine at Dell Medical School at The University of Texas in Austin, exploring lessons learned from the coronavirus pandemic and outlining an approach for creating COVID-19 Centers of Excellence. During the early months of the COVID-19 […]
Go to Top